Anzeige
Mehr »
Donnerstag, 30.10.2025 - Börsentäglich über 12.000 News
Weltweiter Kaliboom treibt Nachfrage - ACM positioniert sich im 93,5 Mrd. USD-Markt bis 2032!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A4ZZ0Z | ISIN: US7469641051 | Ticker-Symbol: DB0
Tradegate
29.10.25 | 14:14
2,200 Euro
-2,65 % -0,060
1-Jahres-Chart
Q32 BIO INC Chart 1 Jahr
5-Tage-Chart
Q32 BIO INC 5-Tage-Chart
RealtimeGeldBriefZeit
2,2002,28009:21
2,2002,28008:45

Aktuelle News zur Q32 BIO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
21.10.Q32 Bio Inc. - 8-K, Current Report1
21.10.Q32 Bio Announces Completion of Enrollment in Part B of SIGNAL-AA Phase 2a Clinical Trial of Bempikibart for Alopecia Areata78-- SIGNAL-AA Part B exceeded target enrollment based on demand from patients; trial size increased to 33 patients -- WALTHAM, Mass., Oct. 21, 2025 /PRNewswire/...
► Artikel lesen
06.08.Q32 Bio August 2025 slides: Bempikibart shows durable response in alopecia areata11
06.08.Q32 Bio GAAP EPS of -$0.7812
06.08.Q32 Bio Inc. - 10-Q, Quarterly Report-
06.08.Q32 Bio Inc. - 8-K, Current Report-
06.08.Q32 Bio Reports Second Quarter 2025 Financial Results and Provides Corporate Update200-- Dosing of patients in Part A open-label extension (OLE) and Part B of SIGNAL-AA ongoing; SIGNAL-AA Part B topline data readout on-track for 1H'26 -- -- Strengthened...
► Artikel lesen
11.07.Pre-market Movers: Above Food Ingredients, Future FinTech Group, LM Funding America, Capricor Therapeutics, Q32 Bio1.130OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.15 A.M. ET).In the Green Above Food Ingredients Inc. (ABVE) is up over 115%...
► Artikel lesen
Q32 BIO Aktie jetzt für 0€ handeln
25.06.Q32 Bio Inc. - 8-K, Current Report1
25.06.Q32 Bio names interim chief medical officer1
17.06.Q32 Bio Inc. - 8-K, Current Report1
23.05.Q32 Bio erhält Mitteilung über Nichteinhaltung der Nasdaq-Vorschriften9
23.05.Q32 Bio Inc. - 8-K, Current Report2
08.05.Q32 Bio GAAP EPS of -$0.903
08.05.Q32 Bio Inc. - 10-Q, Quarterly Report2
08.05.Q32 Bio Inc. - 8-K, Current Report1
08.05.Q32 Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update245-- First patient dosed in SIGNAL-AA Phase 2a Part B; topline data readout on-track for 1H'26 -- -- First patient dosed in SIGNAL-AA Part A open-label extension (OLE)...
► Artikel lesen
30.04.Q32 Bio Announces FDA Fast Track Designation Granted to Bempikibart (ADX-914) for the Treatment of Alopecia Areata218WALTHAM, Mass., April 30, 2025 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative...
► Artikel lesen
16.04.Q32 Bio Doses First Patients in Both Part A Open-Label Extension and Part B of SIGNAL-AA Phase 2a Trial Evaluating Bempikibart in Alopecia Areata211-- SIGNAL-AA Part B topline data readout on-track for 1H'26 -- WALTHAM, Mass., April 16, 2025 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio" or the "Company")...
► Artikel lesen
11.03.Q32 Bio Reports Fourth Quarter 2024 Financial Results and Provides Corporate Update209-- Presented bempikibart SIGNAL-AA Phase 2a Part A alopecia areata (AA) data demonstrating encouraging clinical activity and highlighting the potential to be a differentiated...
► Artikel lesen
Weiter >>
25 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1